Growth hormone and heart failure: Oxidative stress and energetic metabolism in rats

被引:25
作者
Seiva, F. R. F. [3 ]
Ebaid, G. M. X. [3 ]
Castro, A. V. B. [3 ]
Okoshi, K. [3 ]
Nascimento, A. [3 ]
Rocha, K. K. H. [1 ]
Padovani, C. R. [2 ]
Cicogna, A. C. [2 ]
Novelli, E. L. B. [1 ]
机构
[1] Sao Paulo State Univ, UNESP, Inst Biol Sci, Dept Chem & Biochem, BR-18618000 Sao Paulo, Brazil
[2] Sao Paulo State Univ, UNESP, Inst Biol Sci, Dept Stat, BR-18618000 Sao Paulo, Brazil
[3] Sao Paulo State Univ, UNESP, Sch Med, Dept Clin & Cardiol,Postgraduat Course, BR-18618000 Sao Paulo, Brazil
关键词
growth hormone; oxidative stress; energy metabolism; heart failure;
D O I
10.1016/j.ghir.2007.11.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Several evidences point for beneficial effects of growth hormone (GH) in heart failure (HF). Taking into account that HF is related with changes in myocardial oxidative stress and in energy generation from metabolic pathways, it is important to clarify whether GH increase or decrease myocardial oxidative stress and what is its effect on energetic metabolism in HF condition. Thus, this study investigated the effects of two different doses of GH on energetic metabolism and oxidative stress in myocardium of rats with HF. Male Wistar rats (n = 25) were submitted to aortic stenosis (AS). The HF was evidenced by tachypnea and echocardiographic criteria around 28 weeks of AS. The rats were then randomly divided into three groups: (HF) with HF, treated with saline (0.9% NaCl); (HF-GHI), treated with 1 mk/kg/day recombinant human growth hormone (rhGH), and (HF-GH2) treated with 2 mg/kg/day rhGH. GH was injected, subcutaneously, daily for 2 weeks. A control group (sham; n = 12), with the same age of the others rats was evaluated to confirm data for AS. HF had lower IGF-I (insulin-like growth factor-I) than sham-operated rats, and both GH treatments normalized IGF-I level. HF-GH1 animals had lower lipid hydroperoxide (LH), LH/total antioxidant substances (TAS) and glutathione-reductase than HF. Glutathione peroxidase (GSH-Px), hydroxyacyl coenzyme-A dehydrogenase, lactate dehydrogenase(LDH) were higher in HF-GH1 than in HF. HF-GH2 compared with HF, had increased LH/TAS ratio, as well as decreased oxidized glutathione and LDH activity. Comparing the two GH doses, GSH-Px, superoxide dismutase and LDH were lower in HF-GH2 than in HF-GHI. In conclusion, GH effects were dose-dependent and both tested doses did not aggravate the heart dysfunction. The higher GH dose, 2 mg/kg exerted detrimental effects related to energy metabolism and oxidative stress. The lower dose, 1 mg/kg GH exerted beneficial effects enhancing antioxidant defences, reducing oxidative stress and improving energy generation in myocardium of rats with heart failure. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 63 条
[31]   Increased oxidative stress in patients with congestive heart failure [J].
Keith, M ;
Geranmayegan, A ;
Sole, MJ ;
Kurian, R ;
Robinson, A ;
Omran, AS ;
Jeejeebhoy, KN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (06) :1352-1356
[32]   Hormonal profile in patients with congestive heart failure [J].
Kontoleon, PE ;
Anastasiou-Nana, MI ;
Papapetrou, PD ;
Alexopoulos, G ;
Ktenas, V ;
Rapti, AC ;
Tsagalou, EP ;
Nanas, JN .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 87 (2-3) :179-183
[33]   An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations [J].
Kregel, Kevin C. ;
Zhang, Hannah J. .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2007, 292 (01) :R18-R36
[34]   MECHANISM OF THE DIASTOLIC DYSFUNCTION INDUCED BY GLYCOLYTIC INHIBITION - DOES ADENOSINE-TRIPHOSPHATE DERIVED FROM GLYCOLYSIS PLAY A FAVORED ROLE IN CELLULAR CA2+ HOMEOSTASIS IN FERRET MYOCARDIUM [J].
KUSUOKA, H ;
MARBAN, E .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :1216-1223
[35]   Oxidative stress and cardiac disease [J].
Lefer, DJ ;
Granger, DN .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (04) :315-323
[36]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[37]   Oxidative stress and heart failure [J].
MacCarthy, PA ;
Shah, AM .
CORONARY ARTERY DISEASE, 2003, 14 (02) :109-113
[38]  
Mallet RT, 2005, EXP BIOL MED, V230, P435
[39]   Pyruvate: Metabolic protector of cardiac performance [J].
Mallet, RT .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 223 (02) :136-148
[40]   ACROMEGALY AND CARDIOVASCULAR DISORDERS - PROSPECTIVE STUDY [J].
MCGUFFIN, WL ;
SHERMAN, BM ;
ROTH, J ;
GORDEN, P ;
KAHN, CR ;
ROBERTS, WC ;
FROMMER, PL .
ANNALS OF INTERNAL MEDICINE, 1974, 81 (01) :11-18